Furthermore, IGF2BP2 activates the m6A–SLC1A5–mTORC1 signaling axis, thereby enhancing glutamine uptake and promoting pancreatic cancer progression. This evidence concerns the gene IGF2BP2 and pancreatic neoplasm.